ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,303.27
      0.12%
      US Tech 100
      18,065.60
      -0.08%
      Dow Jones
      40,003.59
      0.34%
      Brent Oil
      83.76
      0.67%
      Bitcoin
      67,080.76
      2.82%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Roivant Sciences Ltd (ROIVW)

      7. Roivant Sciences Ltd (ROIVW) Financials

      ROIVW Roivant Sciences Ltd

      2.75
      0.00 (0.00%)
      After Hours
      Last Updated: 20:00:00
      Delayed by 15 minutes

      Roivant Sciences Financial Summary

      The current ROIVW market cap is 2B. The company's latest EPS is USD -1.3883 and P/E is -8.08.

      Income Statement

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 17.05M27.38M21.62M37.1M37.14M
      Operating Income -378.08M-234.17M-276.41M-276.45M-287.53M
      Net Income -349.01M-33.62M-291.82M-304.33M5.1B
      Year End March 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Revenue 67.69M23.8M55.29M61.28M
      Operating Income -553.81M-1.07B-1.35B-1.18B
      Net Income 1.2B-809.23M-845.26M-1.01B

      Balance Sheet

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.2B2.39B2.14B2.07B7.31B
      Total Liabilities 775.82M782.02M802.51M739.91M728.1M
      Total Equity 1.43B1.61B1.33B1.33B6.58B
      Year End March 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Total Assets 2.48B2.59B2.59B2.39B
      Total Liabilities 368.36M527.69M523.7M782.02M
      Total Equity 2.09B2.04B2.04B1.61B

      Cash Flow

      Annual Quarterly
      Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
      USD ($)USD ($)USD ($)USD ($)
      Operating -664.31M-843.39M-249.93M-446.36M-656.81M
      Investing -157.82M-44.27M105k-36.35M5.2B
      Financing 289.13M499.46M7.48M221.35M451.99M
      Year End March 30 2023 2020202120222023
      USD ($)USD ($)USD ($)USD ($)
      Operating -758.75M-552.14M-677.73M-843.39M
      Investing 1.69B-31.7M303.3M-44.27M
      Financing 214.08M456.26M306.79M499.46M

      Stats and Ratios

      Market Cap 2B
      Price to Earnings Ratio -8.08
      Price to Sales Ratio 133.1
      Price to Cash Ratio 4.86
      Price to Book Ratio 5.07
      Dividend Yield -

      Share Statistics

      Shares Outstanding 726.81M
      Average Volume (1 week) 0
      Average Volume (1 Month) 0
      52 Week Change -
      52 Week High -
      52 Week Low -
      Spread (Intraday) 0.4 (15.38%)

      Company Info

      Company Name Roivant Sciences Ltd
      Address clarendon house
      hamilton D0 HM11
      Website https://www.roivant.com
      Industry pharmaceutical preparations (2834)